<DOC>
	<DOCNO>NCT01681524</DOCNO>
	<brief_summary>The study evaluate use Flurpiridaz F18 injection patient CAD determine study drug PET image well SPECT image currently use purpose .</brief_summary>
	<brief_title>Open Label Study Access Flurpiridaz F18 PET MPI Verses SPECT MPI</brief_title>
	<detailed_description>The study assess diagnostic efficacy ( sensitivity specificity ) Flurpiridaz F18 Injection MPI comparison SPECT MPI patient know suspected CAD . Six hundred seventy-two evaluable patient enrol undergo SPECT MPI Flurpiridaz F18 PET MPI . Patients consider enrollment schedule undergo undergone prior ICA without intervention ( either positive negative CAD ) .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Invasive Coronary Angiography Men Women age 18 old see protocol additional detail Women pregnant , lactating , child bear potential practice birth control Unstable cardiac status History coronary artery bypass graft History PCI within past six month See protocol additional detail</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Flurpiridaz F18 Injection</keyword>
	<keyword>Positron Emission Tomography Myocardial Perfusion Imaging</keyword>
	<keyword>Single Positron Emission Computed Tomography</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Myocardia Ischemia</keyword>
	<keyword>Coronary Disease</keyword>
	<keyword>Heart Diseases</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Arteriosclerosis</keyword>
	<keyword>Arterial Occlusive Diseases</keyword>
	<keyword>Vascular Diseases</keyword>
</DOC>